184 related articles for article (PubMed ID: 30156770)
1. Ancillary studies in fine needle aspiration of the kidney.
Renshaw AA; Gould EW
Cancer Cytopathol; 2018 Aug; 126 Suppl 8():711-723. PubMed ID: 30156770
[TBL] [Abstract][Full Text] [Related]
2. Expanding the morphologic spectrum of chromophobe renal cell carcinoma: A study of 8 cases with papillary architecture.
Michalova K; Tretiakova M; Pivovarcikova K; Alaghehbandan R; Perez Montiel D; Ulamec M; Osunkoya A; Trpkov K; Yuan G; Grossmann P; Sperga M; Ferak I; Rogala J; Mareckova J; Pitra T; Kolar J; Michal M; Hes O
Ann Diagn Pathol; 2020 Feb; 44():151448. PubMed ID: 31918172
[TBL] [Abstract][Full Text] [Related]
3. KIT and RCC are useful in distinguishing chromophobe renal cell carcinoma from the granular variant of clear cell renal cell carcinoma.
Wang HY; Mills SE
Am J Surg Pathol; 2005 May; 29(5):640-6. PubMed ID: 15832088
[TBL] [Abstract][Full Text] [Related]
4. Claudin-7 immunohistochemistry in renal tumors: a candidate marker for chromophobe renal cell carcinoma identified by gene expression profiling.
Hornsby CD; Cohen C; Amin MB; Picken MM; Lawson D; Yin-Goen Q; Young AN
Arch Pathol Lab Med; 2007 Oct; 131(10):1541-6. PubMed ID: 17922590
[TBL] [Abstract][Full Text] [Related]
5. Fine-needle aspiration findings of Xp11 translocation renal cell carcinoma metastatic to a hilar lymph node.
El Naili R; Nicolas M; Gorena A; Policarpio-Nicolas ML
Diagn Cytopathol; 2017 May; 45(5):456-462. PubMed ID: 28185421
[TBL] [Abstract][Full Text] [Related]
6. Cytomorphology of clear cell papillary renal cell carcinoma.
Lin X
Cancer Cytopathol; 2017 Jan; 125(1):48-54. PubMed ID: 27636377
[TBL] [Abstract][Full Text] [Related]
7. Rapid and sensitive detection of messenger RNA expression for molecular differential diagnosis of renal cell carcinoma.
Li G; Cuilleron M; Gentil-Perret A; Cottier M; Passebosc-Faure K; Lambert C; Genin C; Tostain J
Clin Cancer Res; 2003 Dec; 9(17):6441-6. PubMed ID: 14695146
[TBL] [Abstract][Full Text] [Related]
8. Typing of renal tumors by morphological and immunocytochemical evaluation of fine needle aspirates.
Strojan Fležar M; Gutnik H; Jeruc J; Kirbiš IS
Virchows Arch; 2011 Dec; 459(6):607-14. PubMed ID: 22052200
[TBL] [Abstract][Full Text] [Related]
9. Accuracy of fine needle aspiration in distinguishing subtypes of renal cell carcinoma.
Renshaw AA; Lee KR; Madge R; Granter SR
Acta Cytol; 1997; 41(4):987-94. PubMed ID: 9250289
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA profile: a promising ancillary tool for accurate renal cell tumour diagnosis.
Silva-Santos RM; Costa-Pinheiro P; Luis A; Antunes L; Lobo F; Oliveira J; Henrique R; Jerónimo C
Br J Cancer; 2013 Nov; 109(10):2646-53. PubMed ID: 24129247
[TBL] [Abstract][Full Text] [Related]
11. Proximal CD13 Versus Distal GATA-3 Expression in Renal Neoplasia According to WHO 2016 Classification.
Brunelli M; Erdini F; Cima L; Eccher A; Fioravanzo A; Gobbo S; Segala D; Ghimenton C; Mazzoleni G; Munari E; Carella R; Martignoni G
Appl Immunohistochem Mol Morphol; 2018; 26(5):316-323. PubMed ID: 27556823
[TBL] [Abstract][Full Text] [Related]
12. A Pilot Study Evaluating Fine-Needle Aspiration Cytology of Clear-Cell Renal Cell Carcinoma: Comparison of Ancillary Immunocytochemistry and Cytomorphological Characteristics of SurePath™ Liquid-Based Preparations with Conventional Smears.
Lee CH; Chung SY; Moon KC; Park IA; Chung YR; Ryu HS
Acta Cytol; 2015; 59(3):239-47. PubMed ID: 26044824
[TBL] [Abstract][Full Text] [Related]
13. Fluorescence in situ hybridization as an adjunct tool in the diagnosis of primary and metastatic renal cell carcinoma in fine needle aspiration specimens.
Kos Z; Williams PA; Belanger EC; Mai KT
Diagn Cytopathol; 2014 Dec; 42(12):1013-23. PubMed ID: 24692327
[TBL] [Abstract][Full Text] [Related]
14. Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney.
Liao SY; Aurelio ON; Jan K; Zavada J; Stanbridge EJ
Cancer Res; 1997 Jul; 57(14):2827-31. PubMed ID: 9230182
[TBL] [Abstract][Full Text] [Related]
15. DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma.
Zhao W; Tian B; Wu C; Peng Y; Wang H; Gu WL; Gao FH
Pathol Res Pract; 2015 Apr; 211(4):303-7. PubMed ID: 25596994
[TBL] [Abstract][Full Text] [Related]
16. Succinate dehydrogenase B: a new prognostic biomarker in clear cell renal cell carcinoma.
Cornejo KM; Lu M; Yang P; Wu S; Cai C; Zhong WD; Olumi A; Young RH; Wu CL
Hum Pathol; 2015 Jun; 46(6):820-6. PubMed ID: 25827535
[TBL] [Abstract][Full Text] [Related]
17. Antimitochondrial antibody (113-1) in the differential diagnosis of granular renal cell tumors.
Tickoo SK; Amin MB; Linden MD; Lee MW; Zarbo RJ
Am J Surg Pathol; 1997 Aug; 21(8):922-30. PubMed ID: 9255255
[TBL] [Abstract][Full Text] [Related]
18. Role Of Immunohistochemistry In Subtyping Renal Cell Carcinomas With Overlapping Morphological Features.
Tariq N; Mamoon N; Haroon A; Ali Z; Ahmad IN
J Ayub Med Coll Abbottabad; 2018; 30(3):325-332. PubMed ID: 30465359
[TBL] [Abstract][Full Text] [Related]
19. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases.
Pan CC; Chen PC; Ho DM
Histopathology; 2004 Nov; 45(5):452-9. PubMed ID: 15500648
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of differential diagnosis of kidney tumors by comparative genomic hybridization of fine needle aspiration biopsies.
Vieira J; Henrique R; Ribeiro FR; Barros-Silva JD; Peixoto A; Santos C; Pinheiro M; Costa VL; Soares MJ; Oliveira J; Jerónimo C; Teixeira MR
Genes Chromosomes Cancer; 2010 Oct; 49(10):935-47. PubMed ID: 20629095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
